Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

CD45-AM ADC as promising new approach for safer conditioning prior to bone marrow transplant

Dec. 19, 2018

Pfizer initiates phase III program for its 20-valent pneumococcal conjugate vaccine

Dec. 17, 2018

Anergis completes proof-of-concept study of second-generation COP allergy vaccines

Dec. 17, 2018

Hookipa Biotech initiates phase II study of HB-101 in kidney transplant patients

Dec. 5, 2018

Celon Pharma Sp zoo divulges JAK1 and JAK3 inhibitors

Dec. 4, 2018

Separating graft attacks

Dec. 3, 2018

FDA approves Gamifant for primary hemophagocytic lymphohistiocytosis

Nov. 21, 2018

Interim phase I results show VLA-1601 induces neutralizing antibodies against Zika virus

Nov. 20, 2018

First patient dosed in first-in-human study of NJA-730

Nov. 20, 2018

Rocket Pharmaceuticals announces FDA clearance of IND for RP-L201 gene therapy

Nov. 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...